Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus - Wikidata - wikimedia - TriplyDB

Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus

Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus

http://www.wikidata.org/entity/Q27490423

about

Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex West Nile Virus: biology, transmission, and human infection Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity The Complement System in Flavivirus Infections Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model.Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice.A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin.A novel approach for the rapid mutagenesis and directed evolution of the structural genes of west nile virus Complement and viral pathogenesis Mapping the interactions of dengue virus NS1 protein with human liver proteins using a yeast two-hybrid system: identification of C1q as an interacting partner.Antibody-mediated neutralization of flaviviruses: a reductionist view.The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms.A fusion-loop antibody enhances the infectious properties of immature flavivirus particles.Antigenic cooperation among intrahost HCV variants organized into a complex network of cross-immunoreactivity.Complex phenotypes in mosquitoes and mice associated with neutralization escape of a Dengue virus type 1 monoclonal antibody Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine.Impact of viral attachment factor expression on antibody-mediated neutralization of flaviviruses.Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection.A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity.B cell response and mechanisms of antibody protection to West Nile virus.West Nile virus: the complex biology of an emerging pathogen.The human antibody response to dengue virus infection The role of humoral innate immunity in hepatitis C virus infection.Technologies for the development of West Nile virus vaccines.Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement.Parainfluenza virus 5 upregulates CD55 expression to produce virions with enhanced resistance to complement-mediated neutralization.Interactions of human complement with virus particles containing the Nipah virus glycoproteins Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity.Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants.Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives.The neutralizing capacity of antibodies elicited by parainfluenza virus infection of African Green Monkeys is dependent on complement.Preconceptual Zika virus asymptomatic infection protects against secondary prenatal infection.Development of Antibody Therapeutics against Flaviviruses.

P2860

Q21090770-73F83ACD-FE0E-4A43-ACA0-58BEFD6DF874 Q24737461-6FE58F4C-42F5-48A1-B9C8-14318C3ED0E4 Q26865618-861ACCE0-F451-4999-AAF5-7FAFD30321D8 Q27490937-D542ABF6-30D6-4EEB-93D3-0839C4FCB960 Q27654848-1B86F8CE-63AB-4297-96A5-6C0A3EFF369E Q28954726-E57CA2FF-424F-4C69-8802-A74CEE3FD315 Q30389407-488968F9-3BD6-48AC-A246-841A195DB118 Q33911897-236DBFE4-715E-49BE-AE9D-030896418145 Q33954392-C1696181-CAA3-4E5E-9957-ABCD24AC6EFF Q34089838-94EF0895-A229-4D3A-9E3F-3D967980B338 Q34132718-FF83E01F-E192-4681-8240-CC24B6E38BF3 Q34162421-6532F845-2558-477A-82BF-73207964E1E0 Q34629343-D02FA473-CB80-416A-9C21-CB9E95296B6E Q34999617-C70F482B-9E2E-48E1-BEC6-3C440C580E69 Q35069160-F6479DDE-74E3-4A11-8DA7-CCBB4BEEA165 Q35213495-8EF618AF-6DC3-4BF6-9F06-7ED38E8B2BAF Q35531167-9B9E543E-D35B-446D-9593-32B91895050A Q35531326-5872FA90-B4A1-4364-A066-C4D5B82F024C Q35669397-1B9A8FC6-DE59-4031-B4AA-5793E1B94FC3 Q35854520-FE468923-DAA8-412F-9AE5-86F2A341F842 Q36559797-C1C8BFCE-7F99-4323-92F7-243626B95F7D Q36697323-72FF1939-2E2E-493D-86AF-3FF1FA7C2A2B Q36789989-75D3B0BE-4D01-4F0A-9AEB-A4A1AE6F284F Q37012203-B1DB4A8B-B70F-4F05-B9F3-40A252037C2F Q37448171-025E2916-F2A7-4087-B5EA-AF3E02C64CEB Q37524313-238F7F22-87E7-4749-93AE-39CE3F2F2E32 Q37673123-89B91904-12B8-4FD8-BADD-484E67F9F528 Q37876095-0671C930-462A-40BA-91E5-A93B195B622B Q37987124-A00AA697-B43A-4697-A7D6-8779E88BDAA5 Q37987129-8CF80156-13D6-4140-801A-D391287D7F1E Q38269151-3526438C-BCD8-44AB-8AF2-F635D08C39A5 Q38697863-0E4BA89B-23F5-45B6-A4E0-736A868387FA Q38752894-D15C8ED5-7A14-48CF-86B7-0C67F0B6B0BE Q39568171-684C2B5F-3303-4DA5-A232-DFA48027AFE6 Q40078229-8C09E753-E037-43F5-910E-9421A4620ED6 Q40201894-3A2C1CCD-6135-4290-8392-BE059F6598D8 Q40295939-B42526FE-A7BD-4456-B592-810D97B2F260 Q42174484-D1F6417F-CB0E-4026-910B-5A9B86A319B3 Q45324741-FD9C550B-4ECE-440A-BF94-EE4327F9171F Q47558158-82A47CAD-3351-46E3-9F0F-7C6C45D5DA32

P2860

Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus

http://www.wikidata.org/entity/Q27490423

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Complement Protein C1q Reduces ...... tralization of West Nile Virus

@ast

Complement Protein C1q Reduces ...... tralization of West Nile Virus

@en

Complement Protein C1q Reduces ...... tralization of West Nile Virus

@nl

type

label

Complement Protein C1q Reduces ...... tralization of West Nile Virus

@ast

Complement Protein C1q Reduces ...... tralization of West Nile Virus

@en

Complement Protein C1q Reduces ...... tralization of West Nile Virus

@nl

prefLabel

Complement Protein C1q Reduces ...... tralization of West Nile Virus

@ast

Complement Protein C1q Reduces ...... tralization of West Nile Virus

@en

Complement Protein C1q Reduces ...... tralization of West Nile Virus

@nl

P1433

Q27490423-A53E617F-BEC5-4267-B2ED-5BAEF6F85E86

P1476

Q27490423-AFDB60D7-E78B-4497-8E96-F4B341CC7F31

P2093

Q27490423-2923C6AA-FBE4-4732-A6D3-ED512BAB7129

Q27490423-2AAA18A5-C9DE-4E81-9B7E-22FABBF8953A

Q27490423-9A6F1987-1862-4A79-97FC-1254081409B0

Q27490423-B04957BA-9F82-479E-ADF8-FAB52F3FBC33

Q27490423-D4E0A98F-9FF3-45BF-95D2-071059A1D155

Q27490423-EB938B3D-422E-4FBD-89AB-38C8A54765E3

P2860

Q27490423-07E52F9C-1A3A-417C-AA34-48CECA9BF7FF

Q27490423-0A8311CD-2A5A-4A8D-B0F1-375700ED04D8

Q27490423-0FB162B6-DD2C-4472-B96B-0EABFA301577

Q27490423-12E717D8-38B7-472D-82AA-AA34E4F61D17

Q27490423-1A2E7C2E-2631-4077-8DE8-78644725428C

Q27490423-1CD8743C-DFA5-475B-992B-B05340F5C7BB

Q27490423-1E62A0AA-8013-48AA-8102-8AAE74D72122

Q27490423-1EC5BF40-5DC9-406F-9C31-265FD247A4F9

Q27490423-1F085045-E122-4C75-B0FC-96A416313487

Q27490423-21E14362-6FDF-4098-8ACB-3FC956D7C6B3

P304

Q27490423-3613BEB0-DDAC-46A3-93D0-DBF3748882DC

P31

Q27490423-8B398D5F-DC7E-491B-B2DA-2D15C4BBA6E9

P3181

Q27490423-16ED732E-902B-468F-8E49-5B11CFD845ED

P356

Q27490423-347C5F07-2F05-4863-B0ED-ED588EFE2EC4

P433

Q27490423-24FE57D8-06E9-49C5-9D10-CC9354714F9D

P478

Q27490423-2C2E307C-F618-4B9E-9E8F-061E420F3685

P50

Q27490423-2A7F55A8-740E-4CB0-8418-EF6079DB470B

Q27490423-FE300346-2355-415B-AF2C-B13977D7622A

P577

Q27490423-97ABA060-2000-4ECE-9891-39446C7B5687

P5875

Q27490423-25C410A8-13E7-4D94-9A21-4C0E8386C6C5

P698

Q27490423-CE3CDED1-43CC-42EE-B516-DD9B4C62B6AD

P921

Q27490423-17A336EB-CF85-4483-A45F-2902C9F2BE90

Q27490423-BBC9A0C1-B316-4072-B646-2FCDD26886CF

Q27490423-E58C0B23-21DD-4DEC-A7F5-BC5A3E501A0F

P932

Q27490423-DFC98640-5AC8-4BE6-A592-A86B6D81DBF1

P3181

P356

J.CHOM.2009.09.003

P1433

Cell Host & Microbe

P1476

Complement Protein C1q Reduces ...... tralization of West Nile Virus

@en

P2093

Christiane A Jost

http://www.w3.org/2001/XMLSchema#string

Daved H Fremont

http://www.w3.org/2001/XMLSchema#string

Erin Mehlhop

http://www.w3.org/2001/XMLSchema#string

Sergey Gorlatov

http://www.w3.org/2001/XMLSchema#string

Steevenson Nelson

http://www.w3.org/2001/XMLSchema#string

Syd Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q

Role of dendritic cells in antibody-dependent enhancement of dengue virus infection

Complement activation is required for induction of a protective antibody response against West Nile virus infection

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus

West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus

Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein

Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites

P304

381-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2370959

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CHOM.2009.09.003

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Diamond

Theodore C Pierson

P577

2009-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38018548

http://www.w3.org/2001/XMLSchema#string

P698

19837377

http://www.w3.org/2001/XMLSchema#string

P921

West Nile virus

P932

2782387

http://www.w3.org/2001/XMLSchema#string